- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/38 - Sulfur atom attached in position 6
Patent holdings for IPC class C07D 473/38
Total number of patents in this class: 41
10-year publication summary
|
4
|
3
|
5
|
4
|
3
|
1
|
1
|
3
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rhizen Pharmaceuticals AG | 57 |
3 |
| Chiesi Farmaceutici S.p.A. | 959 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1430 |
2 |
| Exelixis, Inc. | 390 |
2 |
| Medizinische Hochschule Hannover | 291 |
2 |
| Oregon Health & Science University | 751 |
2 |
| ATEN Porus Lifesciences Pvt. Ltd. | 5 |
2 |
| Avammune Therapeutics Inc. | 4 |
2 |
| The Regents of the University of California | 20534 |
1 |
| Merck Sharp & Dohme Corp. | 2184 |
1 |
| Amgen Inc. | 4348 |
1 |
| The Regents of the University of Michigan | 4903 |
1 |
| Energenesis Biomedical Co., Ltd. | 11 |
1 |
| Helmholtz-Zentrum fuer Infektionsforschung GmbH | 65 |
1 |
| Institute of Organic Chemistry and Biochemistry ASCR,V.V.I. | 37 |
1 |
| Janus Biotherapeutics, Inc. | 10 |
1 |
| Katholieke Universiteit Leuven | 1253 |
1 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 296 |
1 |
| MANDOM Corp. | 141 |
1 |
| Modernatx, Inc. | 1278 |
1 |
| Other owners | 12 |